Results 41 to 50 of about 7,629 (157)

Probiotic‐Based Materials as Living Therapeutics

Advanced Materials, Volume 38, Issue 1, 2 January 2026.
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio, Graham J. Day, Manuel Salmeron‐Sanchez   +2 more
wiley   +1 more source

Attending to Gyn‐Ecology: Managing the ‘Mess’ of Recurrent Vulvovaginal Thrush

Sociology of Health &Illness, Volume 48, Issue 1, January 2026.
ABSTRACT Previous social science research on gendered experiences of thrush and vulvovaginal health has overlooked, or inadvertently sanitised, the materiality of having a body. Therefore, this study aims to return attention to the material, sensorial, and corporeal dimensions of living with recurrent thrush and use this to broaden our understandings ...
Tori Ford, Sue Ziebland, Sarah Tonkin‐Crine, Gail Hayward, Abigail McNiven   +4 more
wiley   +1 more source

Differentiated approach to the treatment of various forms of vulvovaginal candidiasis [PDF]

Гинекология, 2014
The article presents data on the results of examination and treatment of 55 patients with a diagnosis of «vulvovaginal candidiasis». In the study, the analysis of anamnestic data, and in addition, the clinical evaluation of vaginal discharge and the ...
T Yu Pestrikova, E A Yurasova, Yu V Voronova, T D Kovaleva, O G Scherbakova   +4 more
doaj  

Fluconazole‐Induced Fixed Drug Eruption With Cross‐Reactivity to Clotrimazole—Confirmation With Patch Testing

Case Reports in Dermatological Medicine, Volume 2026, Issue 1, 2026.
First described in 1994, fixed drug eruption (FDE) to fluconazole is uncommon but possibly underdiagnosed. Of these, women with vaginal candidiasis remain the most affected, with on average more than four occurrences prior to diagnosis. We present a case of a 29‐year‐old female who presented after her third episode of an itchy, oedematous, blistering ...
D. S. Sron, P. Martinez, J. Iacobelli, P. Singh, B. M. Ricciardo, Sunil Jaiswal   +5 more
wiley   +1 more source

Health Benefits and Therapeutic Potential of Quercetin

Journal of Food Biochemistry, Volume 2026, Issue 1, 2026.
Quercetin, a polyphenolic compound prevalent in many fruits, vegetables, and other dietary sources, has attracted considerable interest due to its extensive health benefits. This review examines its diverse biological properties, particularly its antioxidant and anti‐inflammatory effects. The study integrates recent scientific findings to elucidate the
Mahendra Aryal, Kim Wei Chan
wiley   +1 more source

Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 23: Suitability of taxonomic units notified to EFSA until September 2025

EFSA Journal, Volume 24, Issue 1, January 2026.
Abstract The qualified presumption of safety (QPS) process was developed to provide a harmonised safety assessment approach to support EFSA Scientific Panels and Units. The QPS approach assesses the taxonomic identity, body of relevant knowledge and safety of microorganisms intentionally added to the food and feed chain.
EFSA Panel on Biological Hazards (BIOHAZ), Ana Allende, Avelino Alvarez‐Ordóñez, Valeria Bortolaia, Sara Bover‐Cid, Alessandra De Cesare, Wietske Dohmen, Laurent Guillier, Liesbeth Jacxsens, Maarten Nauta, Lapo Mughini‐Gras, Jakob Ottoson, Luisa Peixe, Fernando Perez‐Rodriguez, Panagiotis Skandamis, Elisabetta Suffredini, Marianne Chemaly, Pier Sandro Cocconcelli, Pablo Salvador Fernández Escámez, Miguel Prieto Maradona, Amparo Querol, Lolke Sijtsma, Juan Evaristo Suarez, Ingvar Sundh, Fulvio Barizzone, Justine Dastouet, Nadya Doyle, Sandra Correia, Lieve Herman   +28 more
wiley   +1 more source

Genetic predisposition to a recurrent course of vulvovaginal candidiasis [PDF]

Гинекология, 2017
Vulvovaginal candidiasis (VVC) frequently occur in women of childbearing age. 5-10% of these women experience recurrent vulvovaginal candidiasis (RVVC), which is characterized by at least 4 episodes of infection in 12 months.
Sh M Pogosyan, E A Mezhevitinova, A E Donnikov, V N Prilepskaia, O V Burmenskaia, O S Nepsha, A A Bystritskiy   +6 more
doaj  

Chebulinic Acid for Alternative Treatment of Vulvovaginal Candidiasis by Targeting Agglutinin-Like Sequence Protein 3 in Candida albicans: In silico Approach [PDF]

, 2021
Kamal Kant Sharma, Prashant Katiyar
openalex   +1 more source

Determination of Effect of Morus alba Extract and Lactobacillus rhamnosus on Vaginal Microbiota and SAP Gene (1–10) Profile With Candida albicans Exosome Administration in Rats

MicrobiologyOpen, Volume 14, Issue 6, December 2025.
The vaginal microbiota plays a crucial role in mucosal immunity and defense against pathogens. Disruption of this balance by Candida albicans exosomes (CAE) upregulates virulence‐related SAP1–10 genes and induces inflammation. In a rat model, treatment with Morus alba (MA) extract and Lactobacillus rhamnosus (LR) demonstrated selective suppression of ...
Mahmut Ucar, Demet Celebi, Ozgur Celebi, Sumeyye Baser, Mustafa Can Guler, Ayhan Tanyeli, Metin Kılıclıoglu, Ahmet Yılmaz, Serkan Yıldırım   +8 more
wiley   +1 more source

Use of natamycin and ketoconazole suppositories in the treatment of recurrent vulvovaginal candidiasis [PDF]

РМЖ. Мать и дитя, 2018
Use of natamycin and ketoconazole suppositories in the treatment  of recurrent vulvovaginal candidiasis I.I. Ivanova1, Yu.E. Dobrokhotova2 1 Pirogov Russian National Research Medical University, Moscow, Russian Federation 2 Clinical ...
I.I. Ivanova, Yu.E. Dobrokhotova
doaj